External Quality Control Testing (for Cellular and Molecular Therapies)

vanced Therapeutic Investigational Medicinal Products, biotechnology products and biological products. The requirement is expected to include specialist QC testing services for in-process, final product and cell bank testing, with testing capabilities potentially including mycoplasma testing, bacter

ial cell bank testing, mammalian cell bank testing, specialised viral safety testing, viral clearance studies, sterility testing and cell-based sterility testing. The precise testing requirements may vary by project and NHSBT may require th